NewSquare Capital LLC raised its position in shares of Edwards Lifesciences by 57.8% in the second quarter. Edwards Lifesciences Corporation has a twelve month low of $65.94 and a twelve month high of $87.89. As a group, equities analysts predict that Edwards Lifesciences Corporation will post 2.45 EPS for the current fiscal year. Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Edwards Lifesciences Corporation (NYSE:EW – Free Report). Receive News & Ratings for Edwards Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edwards Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.